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nosis. If acute GVHD is clinically suspected, this may be 
confirmed immediately by skin biopsy and by HLA typing 
of the peripheral blood lymphocytes. Once GVHD is 
documented, aggressive cytolytic therapy to destroy donor 
lymphocytes seems to be the only therapeutic option. 
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RUPTURE OF INFLOW CONDUITS IN THE TCI-HEARTMATE SYSTEM 
Hans H. Scheld, MD, a Rasjid Soeparwata, MD, a Christof Schmid, MD, a Michael Loick, MD, b Michael Weyand, MD, a 
and Dieter Hammel, MD, a Miinster, Germany 
Improved surgical techniques and sophisticated postop- 
erative care have led to impressive long-term results for 
the implantable l ft ventricular assist device (LVAD) as a 
bridge to transplantation in patients with end-stage car- 
diac failure. However, all of the currently used assist 
devices are less than perfect, and only about 70% of 
patients supported with an LVAD eventually undergo 
transplantation. Apart from preoperative multiorgan fail- 
ure, bleeding, thromboembolism, and infection still jeop- 
ardize the successful outcome and contribute to significant 
postoperative morbidity, because most of the patients 
have one or more of these adverse vents. We report on a 
life-threatening complication, which has occurred in two 
of our six patients with the TCI-HeartMate system 
(Thermo Cardiosystems, Inc., Woburn, Mass.) and which 
seems to occur more often than expected) 
Clinical summar ies  
PATIENT 1. A 56-year-old male patient with end-stage 
ischemic heart disease was awaiting heart transplantation. 
Because of recurrent left ventricular decompensation a d 
ongoing New York Heart Association class IV status, we 
decided to implant the TCI system as a bridge to trans- 
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plantation. The patient fulfilled all criteria defined for 
patient selection. The LVAD was implanted with the 
heart beating, as has recently been described for the 
Novacor system (Baxter Healthcare Corp, Novacor Div., 
Oakland, Calif.). 2 Initially, the postoperative course was 
uneventful except for placement of a chest tube for 
left-sided pleural effusion. The patient recovered well, 
with a pump output of 7 to 8 L/rain, and organ function 
steadily improved. He was fully mobile when blood sud- 
denly poured from the cutaneous exit of the drive line on 
postoperative day 22. A chest x-ray film revealed widening 
of the mediastinal structures but otherwise normal find- 
ings. After a sudden drop of the hemoglobin and hemat- 
ocrit levels, the preperitoneal device pocket was reopened 
and massive clots poured out, suggesting severe bleeding. 
Immediate sternotomy was performed and extracorporeal 
circulation was instituted on an emergency basis. A trans- 
verse tear of 2 to 3 mm within the inflow conduit close to 
the proximal edge of the metallic age support, protecting 
the Dacron conduit, became evident. Because of the 
massive blood loss, the left atrial filling pressure decreased 
and air was sucked into the lacerated Dacron tube of the 
inflow conduit. The LVAD was stopped immediately and 
the tear in the inflow conduit closed with felt-patch 
reinforced sutures, French glue, 3" 4 and double wrapping 
with a size 24 Dacron prosthesis. TCI LVAD support was 
reinstituted and no residual leakage was present. Despite 
meticulous deairing of the LVAD, massive cerebral air 
embolism caused brain death during the postoperative 
period. Pathologic examination confirmed rupture of the 
inflow conduit (Fig. 1). 
PATmNT 2. A 35-year-old man with progressive deterio- 
ration as a result of dilative cardiomyopathy and recurrent 
ventricular arrhythmias (Lown IVb) underwent implanta- 
tion of the TCI LVAD system. His condition had deteri- 
orated steadily despite high-dose catecholamine ad- 
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Fig. 1. Rupture of the inflow conduit in patient 1. Fig. 2. Rupture of the inflow conduit in patient 2. 
ministration and placement of an intraaortic balloon 
pump. The postoperative course was uneventful, and the 
patient was discharged to his home in excellent condition 
with an exercise capacity of 75 W. After 147 days, a 
suitable donor heart became available and the patient was 
scheduled for transplantation. Intraoperatively, extensive 
adhesions rendered explantation of the LVAD difficult. 
When the inflow conduit was approached, a circumscribed 
encapsulated hematoma of approximately chicken egg 
size (6 × 3 × 3 cm) was evident originating from the 
conduit close to the inflow valve. With removal of the 
clots, a similar tear within the Dacron tube was visible. 
Inasmuch as the patient was already receiving extracorpo- 
real circulation, the LVAD was immediately halted to 
prevent aspiration of air and resulting air embolism. The 
conduit was clamped and the transplant procedure com- 
pleted in a standard fashion. The postoperative course 
was uneventful and the patient was discharged to his 
home (Fig. 2). 
The assortment of LVADs demonstrates that no system 
currently guarantees maximal reliability and security for 
the patient. Many different materials have been used in 
fabrication, and ongoing clinical and laboratory research 
is associated with continuous device modification and 
improvement. Reports of mechanical failures are sparse. 5 
In 1988, a threaded outflow connector loosened in one 
patient, who required reoperation. Subsequently, the de- 
sign was modified and a locking mechanism incorporat- 
ed. 6 Very recently, Mehta and Pae 1 reported on a patient 
with erosion of the inlet cannula of the TCI system. 
Personal communications have revealed similar problems 
at other institutions. In our two patients, multiple trans- 
verse tears developed within the inflow conduit, presum- 
ably related to erosion of the Dacron tube by the edge of 
the covering metallic cage. Inasmuch as bleeding in the 
first patient became evident after mobilization, one may 
hypothesize that repetitive and inadequate bending of the 
conduit may have resulted in erosion of the Dacron tube. 
The adjacent inflow valve with its rigid anulus may 
additionally act as an anchor, thus increasing wall stress 
and promoting the laceration. We do not think that the 
Dacron tube is unsuitable, because valved Dacron con- 
duits are not new and their durability has been proved by 
aortic operations. 
It has been stated that the shorter inflow cannula of the 
TCI system is more advantageous than that of the Nova- 
cor systems in terms of placing the pump in the upper 
portion of the abdomen, below the costal margin. 7 It is 
possible that a longer inflow conduit may be less prone to 
bending forces during patient mobilization. Moreover, if 
rupture of the inflow conduit is suspected, preparation is
hard to achieve during surgical revision and the short TCI 
inflow conduit renders exposure ven more difficult. Apart 
from tremendous bleeding, aspiration of air through the 
lacerations may also seriously jeopardize the patient's 
condition, particularly the cerebral function, during sub- 
sequent ransplantation or other surgical procedures. In 
this situation, extracorporeal circulation must be insti- 
tuted immediately and the LVAD stopped before com- 
plete exploration. Aggressive surgical management is
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surely warranted, as stated by Mehta and Pae. 1 Theoret- 
ically, inflow valve dysfunction may occur as well, even if 
it seems unlikely. The metallic sheath has since been 
redesigned and is now less mobile, because it is fixed to 
another metallic ring by a string. 
In conclusion, rupture of the inflow conduit close to the 
inflow valve is a life-threatening complication of the TCI 
system with the mobile cage support, which occurs more 
often than expected. Possible mechanisms include multi- 
ple bending limited by the metallic age support resulting 
from suboptimal placement, while the valvular anulus 
might be acting as an anchor. Patients with possible 
bleeding should receive aggressive treatment, even though 
exchange and replacement of the inflow conduit is a 
demanding task. The metallic sheath has recently been 
redesigned, and future patients may no longer be at risk 
for this complication. 
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NODULAR PULMONARY AMYLOIDOSIS 
Francis J. Podbielski, MD, Darren G. Nelson, MD, Gurney F. Pearsall, Jr., MD, Guillermo D. Marquez, MD, and 
Mark M. Connolly, MD, FACS, Chicago, Ill. 
Pulmonary amyloid deposition generally occurs with 
concurrent primary systemic amyloidosis. Localized forms 
of pulmonary amyloidosis are rare and appear most 
frequently as an incidental lower lobe finding in chest 
radiographs. Tissue for diagnosis can be acquired by 
bronchoscopic, omputed tomography-guided, thoraco- 
scopic, or open biopsy techniques. Our patient had a 
nonproductive cough and multiple new lung nodules that 
led to open biopsy and diagnosis. 
Although pulmonary amyloid is frequently found at 
autopsy as a sequela of primary systemic amyloidosis, 
cardiac failure resulting from amyloid deposition contrib- 
utes to the patient's death in the majority of cases. Median 
survival time for 21 patients with this condition in a series 
reported by Utz, Swensen, and Gertz 1 was 16 months. 
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Twelve percent o 25% of patients with systemic amyloid 
disease have multiple myeloma. 
Pulmonary amyloid deposition ot associated with sys- 
temic disease occurs in three anatomic distributions: 
tracheobronchial, parenchymal, and senile (or diffuse). 
Dyspnea, cough, and hemoptysis are symptoms of tra- 
cheobronchial myloidosis, with the average patient age 
being between 53 and 62 years. Management strategies 
include observation, bronchoscopic resection, laser abla- 
tion, and lung resection. The senile or diffuse form is 
generally asymptomatic. In one autopsy series 2 diffuse 
amyloidosis was present in approximately 10% of patients 
older than age 80 years and in 50% of patients older than 
age 90. The localized parenchymal form of the disorder is 
found in fewer than half of all patients with isolated 
pulmonary amyloid. 
Clinical summary. A 65-year-old woman had had a 
nonproductive cough for 2 months. She denied fever, 
night sweats, weight loss, and hemoptysis. Past medical 
history included mild hypothyroidism treated with oral 
levothyroxine, no exposure to chemicals or asbestos, 
and a history of working as a registered nurse in a 
tuberculosis anitorium in the 1950s, with a positive 
purified protein derivative (PPD) tuberculin skin reac- 
tion when last tested in 1968. A chest radiograph 
performed 4 years before presentation i preparation 
for an orthopedic procedure showed several small 
